Abstract
Laser of the entire area of the neovascular lesion is the only proven treatment for subfoveal choroidal neovascularization secondary to age- related macular degeneration with a poor natural history. However, there are some limiting factors such as patient eligibility, a significant decline in visual acuity after treatment, and a very low possibility of a final vision of 20/100 or better. Although no large benefit of other treatment modalities, such as indocyanine green videoangiography-guided laser photocoagulation, surgical removal of neovascular membranes, and radiation therapy, has yet been proven, carefully selected patients may be suitable candidates for such treatments. This article reviews the status of treatment modalities for subfoveal choroidal neovascularization secondary to age-related macular degeneration, including laser photocoagulation of the entire area of the neovascular lesion, and discusses factors prognostic of visual outcome in these treatment options.
| Original language | English |
|---|---|
| Pages (from-to) | 31-39 |
| Number of pages | 9 |
| Journal | Seminars in Ophthalmology |
| Volume | 13 |
| Issue number | 1 |
| Publication status | Published - 1998 |
Fingerprint
ASJC Scopus subject areas
- Ophthalmology
Cite this
Treatment options in subfoveal choroidal neovascularization secondary to age-related macular degeneration. / Shiraga, Fumio; Takasu, Ippei; Shiragami, Chieko.
In: Seminars in Ophthalmology, Vol. 13, No. 1, 1998, p. 31-39.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment options in subfoveal choroidal neovascularization secondary to age-related macular degeneration
AU - Shiraga, Fumio
AU - Takasu, Ippei
AU - Shiragami, Chieko
PY - 1998
Y1 - 1998
N2 - Laser of the entire area of the neovascular lesion is the only proven treatment for subfoveal choroidal neovascularization secondary to age- related macular degeneration with a poor natural history. However, there are some limiting factors such as patient eligibility, a significant decline in visual acuity after treatment, and a very low possibility of a final vision of 20/100 or better. Although no large benefit of other treatment modalities, such as indocyanine green videoangiography-guided laser photocoagulation, surgical removal of neovascular membranes, and radiation therapy, has yet been proven, carefully selected patients may be suitable candidates for such treatments. This article reviews the status of treatment modalities for subfoveal choroidal neovascularization secondary to age-related macular degeneration, including laser photocoagulation of the entire area of the neovascular lesion, and discusses factors prognostic of visual outcome in these treatment options.
AB - Laser of the entire area of the neovascular lesion is the only proven treatment for subfoveal choroidal neovascularization secondary to age- related macular degeneration with a poor natural history. However, there are some limiting factors such as patient eligibility, a significant decline in visual acuity after treatment, and a very low possibility of a final vision of 20/100 or better. Although no large benefit of other treatment modalities, such as indocyanine green videoangiography-guided laser photocoagulation, surgical removal of neovascular membranes, and radiation therapy, has yet been proven, carefully selected patients may be suitable candidates for such treatments. This article reviews the status of treatment modalities for subfoveal choroidal neovascularization secondary to age-related macular degeneration, including laser photocoagulation of the entire area of the neovascular lesion, and discusses factors prognostic of visual outcome in these treatment options.
UR - http://www.scopus.com/inward/record.url?scp=0031940116&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031940116&partnerID=8YFLogxK
M3 - Article
C2 - 9567010
AN - SCOPUS:0031940116
VL - 13
SP - 31
EP - 39
JO - Seminars in Ophthalmology
JF - Seminars in Ophthalmology
SN - 0882-0538
IS - 1
ER -